These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 742102)

  • 1. [Effect of the beta blocker penbutolol on human hemodynamic parameters and the heart conduction system].
    Biamino G; Schüren KP; von Leitner E
    Verh Dtsch Ges Inn Med; 1978; (84):697-700. PubMed ID: 742102
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical electrophysiological properties of penbutolol: a non-selective beta-blocking agent.
    von Leitner ER; Biamino G
    Eur J Cardiol; 1980; 12(2):121-8. PubMed ID: 7439238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hemodynamic effects of penbutolol at rest and during exercise in essential hypertension.
    Lund-Johansen P
    Eur J Clin Pharmacol; 1979 Sep; 16(3):149-53. PubMed ID: 499314
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the pharmacology of the beta-receptor blocker penbutolol (author's transl)].
    Kaiser J; Härtfelder G; Lindner E; Schölkens B
    Arzneimittelforschung; 1980; 30(3):420-7. PubMed ID: 6992788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Global and regional left ventricular function in coronary heart disease after beta-blockade and furosemide (author's transl)].
    Nechwatal W; Sigel H; Bitter F; Geffers H; Kress P; Adam WE; Stauch M
    Dtsch Med Wochenschr; 1980 Nov; 105(48):1687-93. PubMed ID: 7439055
    [No Abstract]   [Full Text] [Related]  

  • 6. Penbutolol: comparison of its antihypertensive effect with that of alpha-methyldopa in patients with primary hypertension.
    Vierhapper H; Dudczak R; Waldhäusl W
    Arzneimittelforschung; 1980; 30(6):1008-11. PubMed ID: 7191259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of myocardial function parameters by L- and D-penbutolol--an echocardiography, placebo-controlled double-blind study].
    Grube E; Herzog H; Lüderitz B
    Z Kardiol; 1985 Feb; 74(2):99-105. PubMed ID: 3993154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The excretion of renal enzymes during rest and exercise: a double-blind comparison between placebo and penbutolol.
    Verho M; Färber G; Heinen B; Grötsch H
    Int J Clin Pharmacol Res; 1987; 7(1):27-32. PubMed ID: 2884191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic dose-response effects of i.v. penbutolol in angina pectoris.
    Silke B; Verma SP; Hussain M; Nelson GI; Okoli RC; Taylor SH
    Br J Clin Pharmacol; 1983 Nov; 16(5):529-35. PubMed ID: 6315039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extent of beta-blocking action of S- and R-penbutolol during exercise testing (author's transl)].
    Kober G; Schulz W; Hermann HJ; Kaltenbach M
    Z Kardiol; 1982 Apr; 71(4):289-94. PubMed ID: 6283753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect on myocardial contractility of a new beta-adrenergic receptor blocking drug, penbutolol.
    Sapru RP; Sharma PL
    Br J Clin Pharmacol; 1978 Dec; 6(6):515-20. PubMed ID: 728320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The action of beta-adrenoceptor antagonist penbutolol on the pacemaker current of cardiac Purkinje fibres.
    Achenbach C; Hauswirth O; Wehner HD; Ziskoven R
    Jpn J Physiol; 1981; 31(4):537-45. PubMed ID: 7328905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative beta adrenoreceptor blocking effect of propranolol and penbutalol. Preliminary observations.
    Khanna PK; Balasubramanian V; Chatterji JC; Hoon RS
    J Assoc Physicians India; 1978 Mar; 26(3):143-6. PubMed ID: 32165
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of penbutolol on glomerular filtration.
    Meyer BH; Müller FO; Lötter MG; Iturralde MP; Grigoleit HG
    S Afr Med J; 1981 Aug; 60(6):243-4. PubMed ID: 7020108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in man.
    Bax ND; Jones RW; Lennard MS; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):593-6. PubMed ID: 4005101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of beta 1-partial agonist(ICI 118-587) on plasma catecholamines level and hemodynamics during exercise in congestive heart failure].
    Sato H; Matsuyama T; Ozaki H; Fukushima M; Matsumoto M
    Kokyu To Junkan; 1984 Nov; 32(11):1159-62. PubMed ID: 6151727
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta adrenolytic activity and hemodynamic effects of penbutolol].
    Boissier JR; Coutte R; Advenier C; Giudicelli JF
    Therapie; 1973; 28(6):1251-65. PubMed ID: 4152643
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electrical properties of a new beta-blocker agent, tertatolol, in man].
    Touboul P; Atallah G; Kirkorian G; Lamaud M; Moleur P
    Therapie; 1983; 38(4):371-8. PubMed ID: 6139893
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of penbutolol on lidocaine kinetics.
    Ochs HR; Skanderra D; Abernethy DR; Greenblatt DJ
    Arzneimittelforschung; 1983; 33(12):1680-1. PubMed ID: 6686773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stimulation, stimulus conduction and myocardial excitability of the human heart under oxyfedrin therapy of bradycardic dysrhythmias (author's transl)].
    Diewitz M
    Med Klin; 1974 May; 69(18):806-13. PubMed ID: 4151986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.